DEA issues Immediate Suspension Orders to a Tennessee pharmacy over Controlled Substances Act violations - DEA (.gov)
DEA has issued Immediate Suspension Orders to a Tennessee pharmacy for violations of the Controlled Substances Act, impacting its ability to operate legally.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. The affected Tennessee pharmacy and potentially other pharmacies in the region. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate action required to address compliance issues.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Immediate Suspension Orders have been placed on the pharmacy due to non-compliance with the Controlled Substances Act.
Who it affects
The affected Tennessee pharmacy and potentially other pharmacies in the region.
What you must do
Review compliance with the Controlled Substances Act and rectify any violations to avoid similar suspensions.
Deadline
Immediate action required to address compliance issues.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- What to know about the ban on kratom in North Dakota - northdakotamonitor.com
- Bill Lets Pharmacists Refuse To Fill Prescriptions For Religious Reasons - texasstandard.org
- New Rules to Impact Texas Pharmacies - bipc.com
- Pharmacist’s license suspended after vaccine mixup - Bartlesville Examiner-Enterprise
- State Board of Pharmacy: Ohio GLP-1 Compounders Be Vigilant - bipc.com